Potential renoprotective effects and possible underlying mechanisms of angiotensin receptor-neprilysin inhibitors in cardiorenal syndrome
Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a novel class of medications characterized by their dual action on major cardiorenal regulators, specifically the renin–angiotensin system (RAS) and the natriuretic peptide (NP) system. Sacubitril/valsartan, a pioneering ARNI, has demonstr...
Saved in:
| Main Authors: | Md. Moshiur Rahman, Asadur Rahman, Akira Nishiyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1451450/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiotensin Receptor‐Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure
by: Andreas A. Boehmer, et al.
Published: (2024-08-01) -
Effects of angiotensin receptor–neprilysin inhibition on myocardial energy metabolism and prognosis in patients with acute myocardial infarction complicated by heart failure
by: Caiming Cheng, et al.
Published: (2025-08-01) -
Renoprotective Properties of the Low-Dose Antihypertensive Combination Treatment of Patients with Hypertension Combined with Chronic Pyelonephritis
by: Seredyuk N., et al.
Published: (2013-06-01) -
Cardio-Renal-Metabolic Syndrome in Patients with Chronic Kidney Disease: Relevance of the Problem; Pathogenetic Mechanisms; Diagnostics; Risk Factors; Prognosis; Research and Treatment Perspectives (Literature Review; Clinical Case Description)
by: Kh. Abrahamovych, et al.
Published: (2025-06-01) -
Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment
by: E. V. Reznik, et al.
Published: (2019-03-01)